Find Academic Supervisors

• Immunology
• Epitope mapping
• T cell responses
• +4 more

Thomas Østerbye serves as a Special Consultant and Guest Researcher in the Department of Immunology and Microbiology at the University of Copenhagen's Faculty of Health and Medical Sciences. His research focuses on immunological mechanisms with particular emphasis on epitope mapping, HLA interactions, and autoimmune disease processes. Dr. Østerbye's research interests span immunology with specialized expertise in T cell and antibody epitope mapping, HLA class I and II interactions, and autoimmune disease mechanisms. His work integrates experimental immunology with computational approaches to understand molecular recognition in immune responses. He has developed and applied peptide microarray technologies to study immune responses in conditions such as celiac disease, type 1 diabetes, and infectious disease vaccination. His recent publications demonstrate a consistent research trajectory examining immune responses across multiple disease contexts and technological platforms. The articles reveal a strong focus on developing and applying high-throughput methods for characterizing immune recognition, with applications spanning vaccine development, autoimmune disease mechanisms, and diagnostic approaches. Dr. Østerbye maintains an active research profile with numerous collaborations, particularly with Professor Søren Buus and other immunology researchers across institutions. His work appears in high-impact immunology journals including Frontiers in Immunology, Cell Reports, Journal of Immunology, and Science Immunology. His laboratory work centers on peptide microarray technology and its applications for studying immune responses at molecular resolution. This technical focus enables detailed characterization of antibody and T cell specificities across various disease contexts and vaccine responses.

• Global Seismology
• Body Wave Seismic Imaging
• Ambient Seismic Noise
• +7 more

Dr. Jenny Jenkins is an Assistant Professor in the Department of Earth Sciences at Durham University, specializing in deep Earth structure through seismic imaging techniques. Her research addresses fundamental questions about mantle convection, crustal formation, and core-mantle boundary dynamics using observational seismology. Education: PhD in Deep Earth Seismology, University of Cambridge (2013-2017) MESci Geophysics with Geology, University of Liverpool (2009-2013) Research Focus: Employing an observation-driven approach, Dr. Jenkins investigates seismic discontinuities, mantle plumes, and subduction zones. Her work integrates body wave seismic imaging , ambient noise analysis , and mineral physics to unravel Earth's structure from crustal to core-mantle boundary scales. Current projects target ultra-low velocity zones (ULVZs) and their role in planetary dynamics. Publication Trends: Recent work (2016-2025) shows evolving focus from Icelandic crustal studies to deep Earth heterogeneities, with increasing emphasis on ULVZ characterization near Hawaii. Her research bridges fundamental seismology with applied contexts like geothermal systems and infrastructure monitoring, demonstrating methodological innovation across geophysical subdisciplines. Scientific Recognition: 2018 Keith Runcorn Prize - Royal Astronomical Society PhD Thesis prize Mentorship & Service: Actively supervises graduate students while championing diversity through leadership in Durham's Earth Science EDI Group and the Unlearning Racism in Geoscience (URGE) initiative. Her departmental roles reflect commitment to inclusive geoscience practices and educational outreach. Ongoing Research: Developing advanced seismic imaging techniques to map ULVZ morphology at kilometer-scale resolution, with implications for understanding mantle thermochemical structure and core-mantle interactions.

Eric J. MooreView profile

Professor

• Head and Neck Cancer
• Parotid and Salivary Gland Surgery
• Microvascular Reconstructive Surgery
• +4 more

Dr. Eric J. Moore is a Professor of Otolaryngology and serves as the Chair of the Department of Otolaryngology-Head and Neck Surgery at Mayo Clinic. He holds multiple consultative appointments across the institution, including in the Division of Oral Diagnosis and Oral and Maxillofacial Surgery (Department of Surgery), Department of Neurosurgery, and Department of Pediatric and Adolescent Medicine. As a leading head and neck cancer surgeon and facial plastic and reconstructive surgeon, Dr. Moore specializes in complex tumor removal and reconstructive surgery. Dr. Moore's research focuses on improving patient outcomes through innovative surgical techniques and treatment strategies. His primary research areas include parotid gland surgery, transoral robotic surgery (where he assisted in the original FDA approval process), deintensification strategies for HPV-related oropharyngeal cancer, and microvascular reconstruction using computer modeling and 3D printing technology. His research aims to minimize incisions, maintain normal tissue, and improve reconstructions to restore patients' appearance and function after cancer surgery. His publication record demonstrates consistent scholarly output with 218 publications spanning from 1999 to 2025, with recent focus on HPV-related oropharyngeal cancer, liquid biopsy techniques, and surgical innovations. Analysis of his recent publications shows a strong emphasis on translational research that bridges laboratory findings with clinical applications, particularly in the areas of precision oncology and surgical innovation. Castle Connolly Top Doctors (2011-2021) Distinguished Clinician Award (2012) Gunnar Holmgren Award (2021) Joseph H. Ogura Memorial Lecturer Award (2017) Academy of Educational Excellence Fellow (2020) Multiple Teacher of the Year awards Distinguished Humanitarian Award (2007) As an educator, Dr. Moore provides mentorship to residents and fellows, with numerous teaching awards recognizing his excellence in medical education. His humanitarian work includes leading and participating in surgical missions worldwide. His clinical practice focuses on head and neck cancer treatment with particular expertise in robotic surgery, microvascular reconstruction, and treatment of HPV-related cancers with minimal morbidity. Dr. Moore's laboratory and clinical research activities are centered at the Mayo Clinic Comprehensive Cancer Center and the Head and Neck Cancer Center, where he leads research efforts to improve surgical outcomes and develop innovative treatment approaches for head and neck cancer patients.

• Lightweight Construction
• Composite Materials
• Computational Mechanics
• +3 more

Professor Luise Kärger serves as faculty at Karlsruhe Institute of Technology (KIT), where she leads the Lightweight Technology Division within the Institute for Vehicle System Technology. Her research focuses on advancing computational and experimental methodologies for lightweight composite structures in automotive applications. Her primary research domains include: Lightweight Construction methodologies for vehicle systems Computational Mechanics of disordered fiber-reinforced materials Manufacturing Process Simulation (injection molding, overmolding, infiltration) Structural Analysis of composite damage mechanisms Fiber-Reinforced Polymer processing optimization Resource-efficient composite manufacturing digitization Professor Kärger maintains an active research portfolio with seven ongoing DFG projects through 2025, demonstrating sustained funding leadership. Her current work bridges multiscale simulation with experimental validation to solve critical challenges in composite material behavior during manufacturing and service life. Her scientific recognition includes: Prestigious DFG Heisenberg Grant for digitizing composite manufacturing processes As a supervisor, she provides students with hands-on experience in advanced simulation techniques and experimental mechanics through industry-collaborative projects. Her group specializes in developing physics-based process models that integrate data analytics with expert knowledge for structural process improvements. The Lightweight Technology Division operates as KIT's specialized hub for composite material innovation, combining high-fidelity manufacturing simulation with structural performance validation to advance next-generation lightweight vehicle components.

Marcos Antonio Martínez SeguraView profile

Assistant Professor

• Geophysics
• Engineering Geology
• Geotechnical Engineering
• +4 more

Marcos Antonio Martínez Segura is an Assistant Professor at the Polytechnic University of Cartagena's School of Civil, Mining and Naval Engineering, specializing in geophysical methods for engineering and environmental applications. His research bridges theoretical geophysics with practical solutions for infrastructure and environmental challenges in southeastern Spain. His primary research interests include Geophysics, Engineering Geology, and Geotechnical Engineering, with specific expertise in Electrical Resistivity Tomography (ERT), Multichannel Analysis of Surface Waves (MASW), Ground-Penetrating Radar (GPR), and UAV photogrammetry. He focuses on landslide detection , mining tailings characterization , historic building preservation , and environmental monitoring of agricultural waste , often integrating multiple geophysical techniques for comprehensive site characterization. His work demonstrates strong regional relevance to Spain's geological and environmental contexts. Analysis of his recent publications (2023-2025) reveals a dominant trend toward Python-based software development for geophysical data processing, particularly for ERT applications in hazard detection. His research consistently emphasizes multi-method geophysical integration (ERT/GPR/MASW) for solving complex subsurface problems, with 80% of recent work focused on case studies in southeastern Spain addressing mining legacy sites, agricultural pollution, and cultural heritage preservation. Notably, he has expanded into educational technology with augmented reality applications for engineering education.

• Cardiac Electrophysiology
• Arrhythmia Mechanisms
• Cardiac Structural Remodeling
• +5 more

Thomas Jespersen is a Professor at the Department of Biomedical Sciences within the Faculty of Health and Medical Sciences at the University of Copenhagen. His research focuses on pathological changes in cardiac structure and electrophysiology leading to cardiac dysfunction and arrhythmias, particularly those driven by lifestyle risk factors including sleep apnea, obesity, and vascular disorders. His research interests integrate translational approaches combining human studies with in vivo and ex vivo large animal and rodent models, supported by cellular, histological, and molecular analyses. Advanced cardiac imaging techniques including MRI, elastography, and electro-anatomical mapping form the cornerstone of his investigations into cardiac structural and electrical remodeling. Analysis of his 2025 publication portfolio reveals strong emphasis on cutting-edge cardiac interventions (pulsed-field ablation), AI applications in cardiology, obesity-related cardiac pathology, and novel diagnostic approaches for arrhythmias. Key thematic areas include atrial fibrillation mechanisms, ventricular tachycardia ablation, cardiac amyloidosis diagnosis, and obesity-induced myocardial damage. His research group maintains active international collaborations across multiple continents, with significant contributions to understanding arrhythmia pathophysiology through both clinical and experimental models.

Nikhil JoshiView profile

Associate Professor

• Tumor Immunology
• Cancer Immunotherapy
• T cell biology
• +7 more

Nikhil Joshi, PhD is an Associate Professor with Tenure in the Department of Immunobiology at Yale School of Medicine. He serves as Co-leader of the Cancer Immunology Program at Yale Cancer Center and maintains affiliations with multiple Yale research initiatives including the Yale Center for Immuno-Oncology, Human and Translational Immunology Program, and Immunology Liver Center. His research focuses on understanding immune cell interactions with developing tumors, particularly investigating how T cell subtypes function in the tumor microenvironment using complex mouse models. The Joshi Lab combines advanced genetic modeling with immunologic techniques to address fundamental questions in tumor immunology. Analysis of recent publications (2022-2025) reveals a strong focus on T cell biology in cancer, with particular emphasis on T cell exhaustion mechanisms, immunoediting processes, tertiary lymphoid structures, and metabolic influences on tumor immunity. His work spans both basic immunological mechanisms and translational applications for cancer immunotherapy. Class of 1961 Cancer Research Award, Yale Cancer Center (2023) Basic Science Research Prize, Yale Cancer Center (2023) Young Investigators in Cancer Research, Pershing Square Sohn Prize (2022) Emerging Leader Award, Mark Foundation (2022) James B. Dougherty MD Award, Lung Cancer Research Foundation (2021) Professor Joshi maintains active research funding as evidenced by his substantial publication record in high-impact journals. His lab trains numerous students and postdocs, with frequent collaborators including Kelli Connolly, Gena Gora Foster, and Eric Fagerberg. The lab participates in multiple interdisciplinary initiatives at Yale, providing students with opportunities to work at the intersection of immunology, cancer biology, and computational approaches. The Joshi Laboratory focuses on engineering models to decode T-cell immunity in cancer, with research spanning tumor differentiation, T cell fate in cancer and health, and mechanisms of action for immune cells in tumor development and suppression.

• Immuno-oncology
• Tumor Microenvironment
• Cancer Immunotherapy
• +5 more

Kurt Schalper, MD, PhD is an Associate Professor of Pathology at Yale School of Medicine with a secondary appointment in Medical Oncology and Hematology. He serves as Director of the Translational Immuno-Oncology Laboratory (T.I.L.) within the Yale Cancer Center and is affiliated with the Yale Center for Immuno-Oncology, the Pathology Research Program in Translational Biomedicine, and the Yale-UPR Integrated HIV Basic and Clinical Sciences Initiative. Dr. Schalper earned his MD from San Sebastian University in 2003 and his PhD from Universidad Catolica de Chile in 2008. His research focuses on understanding the immunobiology of human solid tumors and developing molecular biomarkers for prediction of response or resistance to therapies. His laboratory actively evaluates tumor antigens and immune evasion pathways in lung malignancies, including immune co-inhibitory/stimulatory ligands and receptors, tolerogenic enzymes, immune suppressive cells, antigen presenting/processing machinery, metabolic alterations in the tumor microenvironment, and oncogenic intracellular signaling. Analysis of Dr. Schalper's recent publications (2024-2025) reveals a strong focus on immuno-oncology, with particular emphasis on lung cancer biomarkers, mechanisms of immunotherapy resistance, tumor microenvironment analysis, and development of novel computational approaches for spatial multi-omic data. His work bridges basic science with clinical applications, as evidenced by numerous clinical trial-related publications and collaborations with leading oncologists at Yale. Dr. Schalper maintains an active research program with significant collaboration networks, particularly with David Rimm (57 common publications), Roy Herbst (35 common publications), and Scott Gettinger (14 common publications). His laboratory is involved in multiple clinical trials, including research on mechanisms of sensitivity and resistance to anti-cancer therapy for advanced lung cancer. The Translational Immuno-Oncology Laboratory aims to produce and support high quality translational research in immuno-oncology through standardized analyses of biomarkers and cross-integration with other Yale resources. The lab's work has direct implications for improving cancer immunotherapy approaches and understanding treatment resistance mechanisms.

• Hydrogen Storage
• Magnetism
• Nanomaterials Synthesis
• +3 more

Dr. Palade Petru is a Scientific Researcher II at the National Institute of Materials Physics in Romania, specializing in hydrogen storage materials, magnetic nanomaterials, and advanced characterization techniques. His work bridges fundamental physics with practical energy applications through extensive collaboration with European research networks. Education: PhD in Physics (Condensed Matter Physics), 2002 Master Degree in Physics (Physics of Semiconductors), 1995 Bachelor Degree in Physics (Technological Physics), 1994 Postdoc at University of Padova, Italy (2003-2006) His research focuses on developing hydrogen storage solutions using mechanochemical methods and wet chemistry synthesis of magnetic nanoparticles. He pioneers the application of Mössbauer spectroscopy for local electronic structure analysis, particularly through conversion electron techniques. His computational work employs WIEN2k for band structure calculations of solids and molecules. Current projects target rare-earth-free permanent magnets and nanoconfined complex hydrides for vehicular hydrogen storage. Analysis of his publication trends reveals consistent leadership in magnetic nanomaterial characterization, with recent emphasis on biomedical applications (hyperthermia, drug delivery) and sustainable energy solutions. His work shows strong interdisciplinary integration of materials synthesis, advanced characterization, and computational modeling. Awards: Dragomir Hurmuzescu Prize from the Romanian Academy (2008) for hydrogen storage research He has secured significant research funding through national projects including PCCA PNCDI-2 (rare-earth-free magnets), PARTNERSHIP PNCDI-2 (STOHICO hydrogen storage project), and IDEAS PNCDI-2 (electronic mechanisms in intermetallics). His laboratory develops patented technologies for hydrogen-storing materials and iron nitride magnetic composites. The Laboratory of Magnetism and Superconductivity maintains specialized capabilities in Mössbauer spectroscopy across multiple isotopes, Sievert method hydrogen storage measurements, and Rietveld refinement of XRD data using Maud software.

• Superconductivity
• Magnetism
• Materials Science
• +4 more

Mihai Burdusel is a Scientific Researcher III at the National Institute of Materials Physics (INFIM) in Romania, working in the Laboratory of Magnetism and Superconductivity. His research focuses on superconducting and magnetic materials, particularly MgB2-based compounds, with applications ranging from electromagnetic shielding to biomedical devices. His primary research interests include: Superconductivity, especially MgB2 and related compounds Magnetism and magnetic nanocomposites Spark plasma sintering techniques for material processing Biomedical applications of superconducting materials Terahertz spectroscopy for material characterization Dr. Burdusel's recent publications demonstrate a strong focus on enhancing the superconducting properties of MgB2 through various doping strategies and processing techniques. His work spans fundamental materials science to applied research, with significant contributions to understanding flux pinning mechanisms, critical current density enhancement, and the development of practical superconducting devices. Notably, his research has expanded into biomedical applications, investigating the antimicrobial properties of MgB2 materials for potential use in medical devices and treatments. Dr. Burdusel has been involved in multiple research projects, including "MgB2 based superconducting composite materials: processing and shaping aspects for different magnetic applications" (2020-2022). His collaborative work spans numerous institutions and researchers across Romania and internationally. He maintains an active research laboratory focused on magnetism and superconductivity, with ongoing projects exploring both fundamental properties of materials and their practical applications in various fields.

Daniel GimenezView profile

Professor

• Soil Physics
• Hydrology
• Soil Structure
• +3 more

Daniel Gimenez is a Professor in the Department of Environmental Sciences at Rutgers University, specializing in soil physical processes across multiple spatial scales. His work bridges environmental engineering and earth system science through empirical field investigations and advanced laboratory techniques. Education: Ph.D. from the University of Minnesota Dr. Gimenez's research focuses on quantifying water movement and chemical transport in natural and engineered soils, with particular emphasis on how land use types (golf courses, forests, agriculture) alter hydraulic properties including infiltration rates, saturated hydraulic conductivity, and water retention curves. His soil structure investigations utilize 3D imaging to correlate pore geometry with functional properties, while his global change research examines how elevated CO 2 and precipitation shifts affect soil carbon distribution and porosity. He employs cutting-edge instrumentation including Ground Penetrating Radar (GPR), Time Domain Reflectometry (TDR), and X-Ray Computed Tomography (CT) for field and laboratory measurements, with research sites extending to Norway. His methodological innovations include automated systems for continuous infiltration monitoring and soil water retention characterization. Dr. Gimenez actively mentors graduate students in the Department of Environmental Sciences, guiding research on soil physical processes and their environmental implications through hands-on field and laboratory work.

Clara Prats GavaldaView profile

Associate Professor

• Muscle Metabolism
• Lipid metabolism
• Glucose metabolism
• +3 more

Clara Prats Gavalda serves as an Associate Professor at the Department of Biomedical Sciences within the Faculty of Health and Medical Sciences at the University of Copenhagen. Her research profile is centered at the Biology Center for Healthy Aging and Individualized Health, where she investigates critical aspects of human metabolism and physiology. Her primary research interests focus on skeletal muscle carbohydrate and lipid metabolism regulation during exercise and in metabolic disorders. Dr. Prats Gavalda's work spans muscle metabolism, lipid metabolism, glucose metabolism, and microscopy techniques to understand metabolic processes at cellular and molecular levels. Her research has significant implications for understanding metabolic diseases including obesity, type 2 diabetes, and age-related metabolic decline. Analysis of her recent publications (2019-2024) reveals a strong focus on mitochondrial function in skeletal muscle, metabolic adaptations to exercise and aging, and the physiological responses to dietary interventions. Her work frequently examines how metabolic pathways are altered in conditions like obesity and type 2 diabetes, with particular attention to insulin sensitivity, fuel utilization, and mitochondrial dynamics. Dr. Prats Gavalda collaborates extensively with researchers across multiple institutions globally, as evidenced by her co-authorship on publications with international teams. Her 2024 publication on imaging scientists demonstrates her engagement with research infrastructure development beyond her primary metabolic research focus. Her laboratory work employs advanced techniques including microscopy and mitochondrial respirometry to investigate metabolic processes at high resolution. The consistent publication record across multiple high-impact journals demonstrates sustained research productivity and relevance in the field of metabolic physiology.

• Molecular Oncology
• Cholangiocarcinoma Research
• Cancer Epigenetics
• +3 more

Juan Francisco Lafuente Barquero serves as an Assistant Professor in the Andersen Group at the Biotech Research and Innovation Centre (BRIC), Faculty of Health and Medical Sciences, University of Copenhagen. His research focuses on the molecular mechanisms underlying biliary tract cancers, particularly cholangiocarcinoma and gallbladder cancer, with emphasis on genome instability, epigenetic regulation, and tumor microenvironment dynamics. His research interests span molecular oncology with specific focus on cancer epigenetics , genome instability mechanisms , cholangiocarcinoma pathogenesis , and tumor microenvironment interactions . His work integrates molecular biology, genomics, and cell biology approaches to understand the fundamental processes driving biliary tract cancers, with particular attention to transcription-associated genome instability, cytoskeletal dynamics in malignant transformation, and epigenetic remodeling during cancer progression. Analysis of his publication record reveals consistent contributions to high-impact hepatology and oncology journals including Journal of Hepatology , Trends in Cancer , and Molecular Genetics and Genomics . His research demonstrates evolving focus from fundamental genome stability mechanisms toward translational cancer biology, with increasing emphasis on molecular characterization of biliary tract cancers and identification of potential therapeutic targets. Recent work shows strong international collaboration networks spanning Europe and North America. No scientific awards were explicitly mentioned in the source material Dr. Lafuente Barquero actively collaborates within the Andersen Group led by Professor Jesper B. Andersen, contributing to multiple high-impact publications in liver cancer research. His work demonstrates significant grant-supported research activity through participation in international consortia including the CGR Exome Studies Group, with publications showing substantial citation impact (notably the 2020 Journal of Hepatology paper with 62 Scopus citations). While formal student mentorship isn't explicitly documented, his position as Assistant Professor suggests involvement in training graduate students and postdoctoral researchers within BRIC's academic environment. He operates within the Andersen Group at BRIC, a research environment focused on molecular cancer biology with particular expertise in liver cancers. The group maintains active collaborations with clinical researchers and international consortia, facilitating translational research from basic mechanisms to potential clinical applications in biliary tract cancers.